News for Alexandria Real Estate Equities, Inc. (ARE)

Evercore ISI has increased its price target for Alexandria Real Estate (ARE) from $89 to $91. Despite a downward adjustment in the firm's Funds From Operations

D.R. Horton's earnings and stability are significantly stronger than implied by market pricing. Click here to read an analysis of DHI stock now.

FFO per Share (Diluted, as Adjusted): $2.33 for Q2 2025, up 1.3% compared to the prior quarter.Occupancy Rate: 90.8% at the end of the quarter, down 90 basis p

Jul 22, 2025 / 06:00PM GMTOperator Good day, and welcome to the Alexandria Real Estate Equities second-quarter 2025 conference call. (Operator Instructions) Ple

Explore Alexandria Real Estate's Q2 2025 earnings call insights on robust leasing, build-to-suit initiatives, and market resilience in life sciences.

See why Alexandria Real Estate Equities, Inc. offers deep-value investment with +130% upside potential, robust dividends, and resilience. Click for my ARE update.

Discover why Alexandria Real Estate Equities (ARE) offers value with a 7% yield, strong FFO, strategic asset sales, and future growth opportunities.

Robust market capitalization of $25.7 billion with a significant presence in AAA life science innovation clusters.High occupancy levels and long lease terms co

Alexandria Real Estate Equities (ARE) on Monday posted second-quarter revenue and adjusted funds from operations that topped Wall Street expectations.

Alexandria Real Estate Equities, Inc. (ARE) reported impressive financial results for the second quarter, with revenue reaching $762.0 million. This figure exce

Alexandria Real Estate Equities (ARE) signs its largest life science lease in history for a 466,598 RSF research hub. The 16-year lease will expand Camp

Discover why Alexandria Real Estate Equities offers a top-tier investment opportunity in life sciences REITs with a 7% dividend yield & strong fundamentals.

Alexandria Real Estate offers a top-tier REIT case with a 6.9% yield and deep-value pricing that misprices solid fundamentals. Read why ARE stock is a strong buy.

Alexandria Real Estate Equities is expected to release its fiscal second-quarter earnings later this month, and analysts project single-digit FFO drop.

Alexandria Real Estate Equities has significantly underperformed the Real Estate sector over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%.

Annaly Capital Management offers a huge yield, but continued payments at their present level are a long way from guaranteed. PennantPark Floating Rate Capital is a typically reliable BDC that offers a yield above 11% at recent prices. Investors looking for a quick and easy way to pump up their passive income stream have some interesting options right now.

Alexandria Real Estate Equities (ARE) is a strong buy with attractive valuation, niche focus in life sciences, and long-term growth potential.

Equity REITs increase their share repurchase activities, amounting to $993.2 million in the first quarter. Alexandria Real Estate Equities (ARE) leads the s